VM

VHCP Management Portfolio holdings

AUM $93M
This Quarter Return
+31.53%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$364M
AUM Growth
+$364M
Cap. Flow
+$71.2M
Cap. Flow %
19.58%
Top 10 Hldgs %
87.22%
Holding
22
New
4
Increased
2
Reduced
2
Closed
2

Top Buys

1
JUNO
Juno Therapeutics, Inc.
JUNO
$74.3M
2
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
$13.1M
3
STML
Stemline Therapeutics, Inc.
STML
$4.87M
4
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.37M

Top Sells

1
DYAX
DYAX CORPORATION
DYAX
$14.1M
2
RDUS
Radius Health, Inc.
RDUS
$11.3M
3
NBIX icon
Neurocrine Biosciences
NBIX
$4.76M
4
ALXA
ALEXZA PHARMACEUTICALS INC COM STK NEW (DE)
ALXA
$166K

Sector Composition

1 Healthcare 50.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$74.3M 20.45% +1,749,999 New +$74.3M
ADVM icon
2
Adverum Biotechnologies
ADVM
$64.6M
$73.1M 20.1% 1,382,735 – –
ANAC
3
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$38M 10.46% 1,178,474 – –
BCRX icon
4
BioCryst Pharmaceuticals
BCRX
$1.74B
$21.2M 5.84% 1,744,356 – –
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$21.1M 5.81% 311,853 – –
LRMR icon
6
Larimar Therapeutics
LRMR
$310M
$16.7M 4.59% 541,480 – –
DYAX
7
DELISTED
DYAX CORPORATION
DYAX
$14.1M 3.87% 1,000,659 -1,000,200 -50% -$14.1M
CHRS icon
8
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$13.1M 3.6% +870,269 New +$13.1M
HRTX icon
9
Heron Therapeutics
HRTX
$207M
$11M 3.03% 1,095,734 – –
RDUS
10
DELISTED
Radius Health, Inc.
RDUS
$9.08M 2.5% 233,294 -291,706 -56% -$11.3M
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.43B
$8.57M 2.36% 500,000 – –
STML
12
DELISTED
Stemline Therapeutics, Inc.
STML
$6.08M 1.67% 356,400 +285,400 +402% +$4.87M
OCRX
13
DELISTED
Ocera Therapeutics, Inc.
OCRX
$4.48M 1.23% 703,730 – –
ZSPH
14
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$4.16M 1.14% 100,000 – –
NBSE
15
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3.98M 1.09% 477,000 – –
TXMD icon
16
TherapeuticsMD
TXMD
$12.8M
$3.77M 1.04% 846,500 – –
LPCN icon
17
Lipocine
LPCN
$15.8M
$3.52M 0.97% 669,921 – –
VIRX
18
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.37M 0.38% +536,189 New +$1.37M
NBIX icon
19
Neurocrine Biosciences
NBIX
$13.8B
– – -303,503 Closed -$4.76M
ALXA
20
DELISTED
ALEXZA PHARMACEUTICALS INC COM STK NEW (DE)
ALXA
– – -71,212 Closed -$166K